Jerini AG

Jerini

Jerini develops and commercialises peptide-based drugs to treat rare inflammatory diseases, oncology, and ophthalmology conditions for patients with limited treatment options.

Dyax

This biotechnology firm develops pharmaceutical treatments for hereditary angioedema and other plasma-kallikrein-mediated disorders to assist patients with these rare inflammatory conditions.

PHVS

This company develops oral therapies to treat and prevent hereditary angioedema attacks for patients with rare diseases.

Lassogen

The company develops peptide-based drugs for patients with cancer and autoimmune disorders.

Peroxitech Therapeutics

Peroxitech Therapeutics develops peptide-based treatments for acute lung injury and respiratory distress to serve patients with severe inflammatory conditions.

Apini Therapeutics

This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.

Pharvaris

Pharvaris develops oral bradykinin B2 receptor antagonists to treat patients with hereditary angioedema and other bradykinin-mediated diseases.

Ra Pharma

This biotech company develops synthetic macrocyclic peptide therapeutics for patients with rare complement-mediated diseases such as myasthenia gravis.